Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judy W M Cheng

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Clinical Therapeutics|March 18, 2008
Aliskiren: renin inhibitor for hypertension managementJudy W M Cheng
The Annals of Pharmacotherapy|September 21, 2006
Use of non-aspirin nonsteroidal antiinflammatory drugs and the risk of cardiovascular eventsJudy W M Cheng
Clinical Therapeutics|April 24, 2012
Ticagrelor: oral reversible P2Y(12) receptor antagonist for the management of acute coronary syndromesJudy W M Cheng
Cardiology in Review|December 15, 2004
Tezosentan in the management of decompensated heart failureJudy W M Cheng
Clinical Therapeutics|November 9, 2004
Rosuvastatin in the management of hyperlipidemiaJudy W M Cheng
Clinical Therapeutics|February 14, 2007
Ranolazine for the management of coronary artery diseaseJudy W M Cheng
Clinical Therapeutics|June 17, 2008
Ambrisentan for the management of pulmonary arterial hypertensionJudy W M Cheng
American Journal of Pharmaceutical Education|October 11, 2012
A cardiovascular pharmacotherapy elective course to enhance pharmacy students' literature evaluation skills and ability to apply clinical evidenceJudy W M Cheng
The American Journal of Geriatric Pharmacotherapy|February 22, 2011
Use of digoxin for heart failure and atrial fibrillation in elderly patientsJudy W M Cheng, Iwona Rybak
The Annals of Pharmacotherapy|October 21, 2004
Use of erythropoietin in heart failure managementKrista Caiola, Judy W M Cheng
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Clinical Therapeutics|March 18, 2008
Aliskiren: renin inhibitor for hypertension managementJudy W M Cheng
The Annals of Pharmacotherapy|September 21, 2006
Use of non-aspirin nonsteroidal antiinflammatory drugs and the risk of cardiovascular eventsJudy W M Cheng
Clinical Therapeutics|April 24, 2012
Ticagrelor: oral reversible P2Y(12) receptor antagonist for the management of acute coronary syndromesJudy W M Cheng
Cardiology in Review|December 15, 2004
Tezosentan in the management of decompensated heart failureJudy W M Cheng
Clinical Therapeutics|November 9, 2004
Rosuvastatin in the management of hyperlipidemiaJudy W M Cheng
Clinical Therapeutics|February 14, 2007
Ranolazine for the management of coronary artery diseaseJudy W M Cheng
Clinical Therapeutics|June 17, 2008
Ambrisentan for the management of pulmonary arterial hypertensionJudy W M Cheng
American Journal of Pharmaceutical Education|October 11, 2012
A cardiovascular pharmacotherapy elective course to enhance pharmacy students' literature evaluation skills and ability to apply clinical evidenceJudy W M Cheng
The American Journal of Geriatric Pharmacotherapy|February 22, 2011
Use of digoxin for heart failure and atrial fibrillation in elderly patientsJudy W M Cheng, Iwona Rybak
The Annals of Pharmacotherapy|October 21, 2004
Use of erythropoietin in heart failure managementKrista Caiola, Judy W M Cheng
Pageof 6